Evaluation and Modeling with the Therapeutic Effects Group
Members
Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87
Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18
Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83
Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99
Doctorante
autre
Tel: 04 72 44 81 42
Praticien hospitalier
HCL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier émérite
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01
Post-doc
UCBL
Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20
Doctorante
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 1 to 30 publications on 613 in total
A Machine Learning Algorithm to Predict the Starting Dose of Daptomycin
Clinical Pharmacokinetics . 63 ( 8 ) : 1137-1146
Journal article
see the publicationThe expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
The Lancet Respiratory Medicine . 12 ( 11 ) : 888-900
Journal article
see the publicationLumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy
Clinical Pharmacokinetics . 63 ( 3 ) : 333-342
Journal article
see the publicationComité de surveillance indépendant dans les essais cliniques : de la justification scientifique à l’organisation
Therapies . 79 ( 1 ) : 99-110
Journal article
see the publicationData Monitoring Committees and clinical trials: from scientific justification to organisation
Therapies . 79 ( 1 ) : 111-121
Journal article
see the publicationEstimating individualized treatment effects using an individual participant data meta-analysis
BMC Medical Research Methodology . 24 ( 1 ) : 74
Journal article
see the publicationFondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison
HEGEL - HEpato-GastroEntérologie Libérale . N° 4 ( 4 ) : 347-358
DOI: 10.3917/heg.134.0347
Journal article
see the publicationRapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health
BMJ Evidence-Based Medicine . 29 ( 1 ) : 1-5
Journal article
see the publicationQu’est-ce qu’une thérapeutique ? Analyse conceptuelle de la notion de placebo, d’effet placebo, d’effet spécifique et de thérapeutique
HEGEL - HEpato-GastroEntérologie Libérale . N° 4 ( 4 ) : 325-334
DOI: 10.3917/heg.134.0325
Journal article
see the publicationOlaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network
Neuro-Oncology Advances . 6 ( 1 )
Journal article
see the publicationCOBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
Pediatric Allergy and Immunology . 35 ( 3 ) : e14112
DOI: 10.1111/pai.14112
Journal article
see the publicationImpact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
Journal of Cystic Fibrosis . 23 : 815 - 822
Journal article
see the publicationA quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022–2023
Vaccine . 42 ( 21 ) : 126160
Journal article
see the publicationTaux de rémissions prolongées à l’arrêt d’un traitement par agoniste du récepteur de la thrombopoïétine au cours de la thrombopénie immunologique : suivi à long-terme de l’étude STOPAGO, cohorte prospective multicentrique
La Revue de Médecine Interne . 45 : A109
Journal article
see the publicationRisk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials
Joint Bone Spine . 91 ( 3 ) : 105673
Journal article
see the publicationDeaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
Biomedicine and Pharmacotherapy . 171 : 116055
Journal article
see the publicationDifficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN ‐France registry
British Journal of Haematology . 204 ( 4 ) : 1476-1482
DOI: 10.1111/bjh.19288
Journal article
see the publicationDaptomycin pharmacokinetic/pharmacodynamic target in staphylococcal infections
Clinical Infectious Diseases .
DOI: 10.1093/cid/ciae018
Journal article
see the publicationPharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication
Therapeutic Drug Monitoring . 46 ( 1 ) : 127-131
Journal article
see the publicationRPEM : Randomized Monte Carlo parametric expectation maximization algorithm
CPT: Pharmacometrics and Systems Pharmacology . 13 ( 5 ) : 759-780
DOI: 10.1002/psp4.13113
Journal article
see the publicationWhat are the available online resources targeting psychosocial burden among stroke survivors and their informal caregivers: A scoping review
Digital Health . 10
Journal article
see the publicationExpositions accidentelles à des toxiques chez les enfants - Étude des données de plusieurs sources de recours aux soins entre 2014 et 2020
: 233 p.
Report
see the publicationUnlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data
Healthcare . 12 ( 2 ) : 208
Journal article
see the publicationExposure to ammonia solution due to substance use: a retrospective study from the French poison centres database (2009–2018)
Clinical Toxicology . : 1-5
Journal article
see the publicationComparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy .
DOI: 10.1093/jac/dkae026
Journal article
see the publicationNirsevimab for Prevention of RSV in Term and Late-Preterm Infants
New England Journal of Medicine . 388 ( 16 ) : 1533-1534
DOI: 10.1056/NEJMc2214773
Journal article
see the publicationNirsevimab for Prevention of Hospitalizations Due to RSV in Infants
New England Journal of Medicine . 389 ( 26 ) : 2425-2435
Journal article
see the publicationCirculating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
iScience . 26 ( 8 ) : 107427
Journal article
see the publicationPlatelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents
Blood . 142 ( 12 ) : 1099-1101
Journal article
see the publication
You also, comment on this article